In Quiet Debut, Alzheimer’s Drug Finds Questions, Skepticism

The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by questions about its price and how well it works.Several major medical cente…

Zimbabwe Government: No COVID-19 Shot, No Work, No Pay

Union leaders have angrily reacted to the Zimbabwean government’s announcement Sunday that workers who have not been vaccinated against COVID-19 will no longer be allowed at work and will not be paid. This is seen as part of efforts to deal with high v…